Transarterial embolization of non-bleeding hepatocellular adenomas: a pilot study

Withdrawn

• Conditions: hepatocellular adenoma; Liver adenoma; 10019815; 10019813

• Registration Number: NL-OMON47079
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

- Hepatocellular adenoma(HCA) * 5 cm
- Age at least 18 years
- Withdrawal from oral contraceptives at least 3 months
- Patient fit to undergo liver resection
- Patient understands both the nature and requirements of the study
- BMI between 18-35
- ASA I-III
- Written informed consent
- No suspicion of HCC (normal Alpha foeto protein level)

Exclusion Criteria

- Inability to give written informed consent
- Men (increased risk of malignant transformation)
- HCA presenting with acute bleeding
- History of hepatic malignancy
- Pregnancy
- Claustrophobia (MRI)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Quality of life<br /><br>tumor size</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>complications<br /><br>Malignant transformation</p><br>